• Sam Supreeth, Khalifa A Al Ghafri, Renjit K Jayachandra, and Zakariya Y Al Balushi.
• Khoula Hospital, Muscat, Oman. Electronic address: supreethsam13@gmail.com.
• World Neurosurg. 2020 Mar 1; 135: 335-338.

BackgroundCandida auris is an emerging superbug which was recently discovered and has spread widely across the world. With a steady rise in incidence involving multisystems, this presents a unique challenge to caregivers.Case DescriptionA 50-year-old man with sickle cell disease, diabetes mellitus, and multiple surgeries presented with progressive low back pain radiating to bilateral limbs and intact neurology. Radiologic and laboratory investigations suggested spondylodiscitis with epidural collection, which was operated with posterior decompression and stabilization. The tissue analysis was reported as C. auris, which was accordingly treated with caspofungin. Magnetic resonance imaging at 4 months showed resolution of infection with return of inflammatory markers to normal.ConclusionsC. auris appears to be an emerging superbug, which is hospital-acquired. All practitioners must be aware of its existence and presentation. Given the low incidence, high mortality, and no clear guidelines of management so far, formulation of any such strategies is complicated. Further studies and research are needed for this superbug.Copyright © 2019 Elsevier Inc. All rights reserved.

33 keywords...

hide…